Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of 40-O-(2-hydroxy)ethylrapamycin for treatment of restenosis and other disorders

Use of 40-O-(2-hydroxy)ethylrapamycin for treatment of restenosis and other disorders

US Patent 6384046 · Granted May 7, 2002

Estimated economic value: $5,412,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Somatostatin analogues2015
Somatostatin analogues2014
Use of a PKC inhibitor2014
Combinations of immunosuppressive agents for the treatment or prevention of graf2013
Indolymaleimide derivatives2013
Somatostatin analogues2011
Indolylmaleimide derivatives2010
Isothiourea derivatives of imadazo[2,1-b]Thiazoles and 5,6-dihydro derivatives t2010
Ergoline derivatives2010
Indolylmaleimide derivatives as PKC inhibitors2010
Somatostatin analogues2009
Piperidine derivatives as CCR5 inhibitors2008